Fertiga is the first provider worldwide on analysis of cumulus cells to improve live birth rates. The test is called the Aurora Test. By analyzing cumulus cells (the cells surround the oocyte), Fertiga can determine the oocyte with the highest quality. The corresponding embryo will be transferred first, resulting in higher live births from the first transfer.

Our aim is to improve fertility treatments to give access to more couples and to reduce the overall burden of the treatment. We strive to have as many women as possible pregnant from the first attempt. Our motto is: one try, one child.

Fertiga is a spin-off company from one of the global IVF leading centers, UZ Brussels in Belgium.

UZ Brussel has been pioneering in IVF, with the first ICSI baby worldwide born in 1992 from the Center of Reproductive Medicine of UZ Brussels.

Fertility

Health Diagnostics

Health Care

Medical Devices

Fertiga

André Rosenthal

Piet Lannoo

Inge van Vaerenbergh

This department focuses on identifying growth opportunities and building strategic partnerships to enhance organizational success.

Business Development

This department oversees clinical laboratory processes and molecular biology research activities.

Clinical Operations

This department provides strategic direction and oversight for the organization.

Fertiga

Org chart

Teams

Business Development

Clinical Operations

Executive Leadership

Offices